Christina Antza | Hypertension | Best Research Article Award

Posted on by Pencis

Assist. Prof. Dr. Christina Antza | Hypertension | Best Research Article Award

Assist. Prof. Dr. Christina Antza, 3rd Department of Internal Medicine, Aristotle University of Thessaloniki, Greece

Assist. Prof. Dr. Christina Antza is a specialist in Internal Medicine and Hypertension at the 3rd Department of Internal Medicine, Aristotle University of Thessaloniki, Greece. She holds an M.D., a Ph.D. in blood pressure measurement methods, and an M.Sc. in Research Methodology. Dr. Antza has extensive experience in hypertension, metabolic syndrome, diabetes, and atherosclerosis. She has worked as a researcher, consultant, and medical educator in Greece and the UK. Recognized with multiple awards and fellowships, she actively contributes to international medical research and education, shaping advancements in cardiovascular and metabolic disease management.

AUTHOR PROFILE

Orcid Profile

🎓 EARLY ACADEMIC PURSUITS:

Dr. Christina Antza began her educational journey at the Fifth High-School of Drama (Junior High School) and Third High School of Drama (Senior High School). She then pursued her Medical Degree at Aristotle University of Thessaloniki, Greece (2007-2013), graduating with an impressive 8/10 grade.

Her passion for research and academia led her to further studies, including:

  • Ph.D. in Internal Medicine (2014-2019) – Focused on blood pressure measurement methods and their ability to predict early vascular aging. She earned a Grade A with Distinction under the supervision of Prof. V. Kotsis.
  • Master of Science in Research Methodology in Medicine and Health Science (2016-2018) – Achieved an outstanding 9/10 grade.
  • Research Fellowship (2019-2020) – Conducted clinical and research work in Diabetes Mellitus and Obesity at the University of Birmingham, UK.
  • Postdoctoral Research (2019-2022) – Specialized in Hypertension and Metabolic Syndrome at Aristotle University of Thessaloniki.
  • Internal Medicine Consultant Certification (2021) – Earned after passing rigorous written and oral examinations.

💼 PROFESSIONAL ENDEAVORS:

Dr. Antza has held various prestigious roles in internal medicine, focusing on hypertension, metabolic syndrome, and endocrinology:

  • Scientific Associate (2013-2014) – Engaged in research and clinical practice in hypertension at the 3rd Department of Internal Medicine, Aristotle University of Thessaloniki.
  • Medical Resident (2016-2021) – Trained at Papageorgiou General Hospital, Aristotle University of Thessaloniki.
  • Academic Fellowship in Hypertension & Metabolic Syndrome (2021-2022) – Focused on clinical practice, independent teaching, and research.
  • Internal Medicine Consultant (2021-2023) – Served at Papageorgiou General Hospital and Bioclinic, offering expertise in hypertension, diabetes, and emergency medicine.
  • Assistant Professor of Internal Medicine – Hypertension (2023-Present) – Currently educating future medical professionals and leading research at Aristotle University of Thessaloniki.

Additionally, she has participated as a Subinvestigator in Phase 2 & 3 Clinical Trials, contributing to advancements in hypertension and metabolic disorders.

📚 CONTRIBUTIONS AND RESEARCH FOCUS ON HYPERTENSION:

Dr. Antza has extensively researched hypertension, metabolic syndrome, diabetes, lipid disorders, and vascular aging. Her work has focused on:

  • Blood Pressure Measurement Techniques (Home, Ambulatory, and Clinical).
  • Atherosclerosis and Cardiovascular Risk.
  • Metabolic Syndrome and Obesity-Related Disorders.
  • Diabetes and Endocrine Disorders.

She has been actively involved in research collaborations with leading medical institutions, including Queen Elizabeth Hospital, Birmingham, UK, where she served as an Honorary Observer (2019-2022) in the Endocrinology Department.

🏆 IMPACT AND INFLUENCE:

Dr. Antza’s work has been recognized with numerous awards and fellowships:

  • Young Fellow of the European Atherosclerosis Society (2019-Present).
  • Young Fellow of the European Hypertension Society (2023-Present).
  • Recipient of multiple Investigator Grants & Travel Awards from the European Society of Hypertension (ESH) and European Atherosclerosis Society (EAS).
  • 1st Place Oral Presentation Award – 8th Panhellenic Congress of the Hellenic Atherosclerosis Society (2019).
  • 2nd Clinical Research Award – 9th Panhellenic Congress of the Hellenic Atherosclerosis Society (2020).
  • Young Investigator Fellowship Award – 89th EAS Virtual Congress (2021).

📖 ACADEMIC CITATIONS & SCHOLARSHIPS:

Dr. Antza’s research has been widely cited in medical literature, influencing clinical guidelines in hypertension and metabolic diseases. Her scholarly excellence has earned her:

  • Ph.D. Scholarship from the Hellenic Society of Atherosclerosis (2014-2015).
  • Postdoctoral Research Scholarship from the State Scholarship Foundation (2019-2021).
  • Award from the Medical Sciences Deanery for Ph.D. Research (2020).

🌍 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Christina Antza is poised to make significant future contributions in the diagnosis and management of hypertension, metabolic syndrome, and cardiovascular diseases. Her expertise in clinical research, education, and innovative treatment strategies will continue to shape internal medicine and patient care.

Her future goals include:
✔ Expanding research on hypertension-related complications and vascular aging.
✔ Leading international collaborations in cardiovascular and metabolic diseases.
✔ Mentoring the next generation of medical professionals and researchers.
✔ Contributing to global guidelines on hypertension and cardiovascular risk management.

Her dedication to patient care, research, and teaching makes her an influential figure in modern internal medicine and hypertension research.

🌟CONCLUSION :

Assist. Prof. Dr. Christina Antza is a dedicated clinician, researcher, and educator in the fields of hypertension, metabolic syndrome, and internal medicine. With a strong academic foundation, international research collaborations, and numerous accolades, she continues to advance medical knowledge and improve patient care. Her contributions to medical education and research have made a lasting impact, inspiring future generations of physicians. As she progresses in her career, Dr. Antza remains committed to innovation, scientific discovery, and excellence in healthcare, shaping the future of cardiovascular and metabolic disease management. Her work stands as a testament to dedication and expertise.

TOP NOTABLE PUBLICATIONS

Clinic, Ambulatory and Home Blood Pressure Monitoring for Metabolic Syndrome: Time to Change the Definition?

Journal: Medicina

Year: 2025

The Microbial Perspective: A Systematic Literature Review on Hypertension and Gut Microbiota

Journal: Nutrients

Year: 2024

The Effects of Olive Oil Consumption on Biochemical Parameters and Body Mass Index of People with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Journal: Nutrients

Year: 2024

Familial Hypercholesterolemia in the Elderly: An Analysis of Clinical Profile and Atherosclerotic Cardiovascular Disease Burden from the Hellas-FH Registry

Journal: Biomedicines

Year: 2024

The Modern Environment: The New Secondary Cause of Hypertension?

Journal: Medicina

Year: 2023

The Importance of Out-of-Office Blood Pressure Measurement, as Highlighted by the Correlation with Left Ventricular Hypertrophy in an Untreated Hypertensive Population

Journal: Medicina

Year: 2023

Ruping Dai | Cardiovascular Anesthesia | Best Researcher Award

Posted on by Pencis

Prof. Dr. Ruping Dai | Cardiovascular Anesthesia | Best Researcher Award 

Prof. Dr.  Ruping Dai, Second Xiangya Hospital, China

Prof. Dr. Ruping Dai is the Director of Anesthesiology at the Second Xiangya Hospital, Central South University, China. He earned his Ph.D. in Clinical Medicine from the National University of Singapore in 2004 and completed postdoctoral research at the Institute of Molecular and Cell Biology, Singapore. Prof. Dai specializes in clinical anesthesia, pain management, intensive care, perioperative medicine, and organ protection. He has led four projects funded by the National Natural Science Foundation of China and has published 24 SCI papers. His accolades include the New Century Talent Support Program (2012) and the Hunan Province Outstanding Youth Fund (2013).

AUTHOR PROFILE

Google Scholar Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Dr. Ruping Dai embarked on his academic journey at the Xiangya School of Medicine, Central South University, where he earned his Bachelor’s degree in Anesthesiology (1993-1998). His thirst for knowledge led him to pursue a Ph.D. in Medicine at the National University of Singapore (2000-2004), where he focused on advanced medical research. He further honed his expertise as a Postdoctoral Fellow at the National Institute of Molecular and Cell Biology, Singapore (2004-2006), gaining in-depth knowledge in molecular and cellular biology applications in anesthesiology.

🏥PROFESSIONAL ENDEAVORS:

Dr. Dai began his career in the Department of Cardiothoracic Surgery, Union Hospital Affiliated to Fujian Medical University (1998-2000), specializing in cardiovascular anesthesia and intensive care. Since October 2006, he has been a Chief Physician and Doctoral Supervisor at the Department of Anesthesiology, Second Xiangya Hospital, Central South University. Over the years, he has played a vital role in clinical anesthesia and Anesthesia Intensive Care Units (AICU), ensuring excellence in patient care and medical education.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR ANESTHESIA:

Dr. Dai’s research primarily focuses on anesthesiology, organ protection, perioperative care, and immunosuppression mechanisms in sepsis. He has led multiple groundbreaking studies on topics such as:

  • Postoperative sepsis mechanisms
  • Perioperative acute lung injury
  • Neuroplasticity and postoperative cognitive dysfunction (POCD)
  • Microglial/macrophage polarization in spinal cord ischemia-reperfusion injury

Dr. Dai has hosted 7 National Natural Science Foundation (NSFC) projects, receiving significant research funding, including:

  • Key Project on Hematogenous Macrophage Role in Postoperative Sepsis (2025-2028) – RMB 2.6 million
  • SIRT5-Mitochondrial Metabolic Axis in Perioperative Acute Lung Injury (2024-2027) – RMB 490,000
  • Macrophage Dysfunction in Sepsis Immunosuppression (2021-2024) – RMB 560,000
  • Microglia Polarization in Spinal Cord Ischemia-Reperfusion Injury (2018-2021) – RMB 540,000

🌍IMPACT AND INFLUENCE:

Dr. Dai holds several prestigious administrative positions, including:

  • Director of Anesthesiology, Second Xiangya Hospital, Central South University
  • Director, Institute of Anesthesiology, Central South University
  • Director, Hunan Anesthesia Clinical Medicine Research Center
  • Director, Hunan Provincial Organ Damage Prevention and Treatment Engineering Center

In academia, he serves as:

  • Deputy Chairman, Hunan Provincial Anesthesiology Committee
  • National Committee Member, Anesthesiology Branch, Chinese Medical Doctor Association
  • Vice Chairman, 13th Youth Committee of the Chinese Medical Association Anesthesiology Branch
  • Deputy Director, Orthopedics Group, Chinese Medical Association Anesthesiology Branch
  • Standing Committee Member, Cardiovascular Anesthesia Branch, Chinese Society of Thoracic and Cardiovascular Anesthesiology

📖ACADEMIC CITES AND SCHOLARLY CONTRIBUTIONS:

Dr. Dai has played a crucial role in education, having authored and co-edited several key textbooks:

  1. Clinical Anesthesiology (First Editor, Science Press, 14th Five-Year Plan)
  2. Postgraduate Textbook: Anesthesiology (Selected Topics of Basic Anesthesia Research, People’s Medical Publishing House, 2014)
  3. Resident Medical Planning Textbook: Anesthesiology (Postoperative Acute Pain Management, People’s Medical Publishing House, 2014)
  4. Co-translator of Miller’s Anesthesiology (7th & 8th editions, Opioids section, 2017)

🏆SCIENCE AND TECHNOLOGY AWARDS:

Dr. Dai’s excellence in research and innovation has earned him several prestigious awards, including:

  • Second Prize of Hunan Natural Science Award (2019)
  • Third “Light of Spirit” Excellent Youth Research Fund – Second Prize
  • Award-winning fund for Young and Middle-aged Excellent Paper Competition at the Chinese Anesthesia Annual Meeting

🔮LEGACY AND FUTURE CONTRIBUTIONS:

As a pioneering figure in anesthesiology, Dr. Dai continues to shape the future of perioperative medicine, critical care, and pain management. His leadership in cutting-edge research, education, and healthcare innovation ensures his lasting impact in the field. Through mentorship and research, he remains dedicated to improving patient outcomes and advancing medical science, setting a benchmark for future anesthesiologists worldwide.

🌟CONCLUSION:

Prof. Dr. Ru-Ping Dai is a distinguished anesthesiologist and researcher at the Second Xiangya Hospital, Central South University, China. As the Director of the Department of Anesthesiology, he has significantly advanced perioperative medicine, focusing on neuroimmune interactions and organ protection. His notable work includes elucidating the roles of brain-derived neurotrophic factor (BDNF) and its precursor, pro-BDNF, in mood disorders, offering new perspectives on neuroimmune crosstalk. Prof. Dai’s dedication to integrating clinical practice with research has enhanced patient care and contributed to the global medical community’s understanding of anesthesiology and neuroscience.

TOP NOTABLE PUBLICATIONS

Brain derived neurotrophic factor (BDNF) contributes to the pain hypersensitivity following surgical incision in the rats

Authors: CQ Li, JM Xu, D Liu, JY Zhang, RP Dai
Journal: Molecular Pain
Year: 2008

Local translation and retrograde axonal transport of CREB regulates IL-6-induced nociceptive plasticity

Authors: OK Melemedjian, DV Tillu, JK Moy, MN Asiedu, EK Mandell, S Ghosh, …
Journal: Molecular Pain
Year: 2014

Early-life social isolation-induced depressive-like behavior in rats results in microglial activation and neuronal histone methylation that are mitigated by minocycline

Authors: HT Wang, FL Huang, ZL Hu, WJ Zhang, XQ Qiao, YQ Huang, RP Dai, F Li, …
Journal: Neurotoxicity Research
Year: 2017

Histone 2B (H2B) expression is confined to a proper NAD+/NADH redox status

Authors: RP Dai, FX Yu, SR Goh, HW Chng, YL Tan, JL Fu, L Zheng, Y Luo
Journal: Journal of Biological Chemistry
Year: 2008

Effects of down-regulation of microRNA-23a on TNF-α-induced endothelial cell apoptosis through caspase-dependent pathways

Authors: W Ruan, J Xu, S Li, L Yuan, R Dai
Journal: Cardiovascular Research
Year: 2012

Development of anxiety-like behavior via hippocampal IGF-2 signaling in the offspring of parental morphine exposure: effect of enriched environment

Authors: CQ Li, YW Luo, FF Bi, TT Cui, L Song, WY Cao, JY Zhang, F Li, JM Xu, …
Journal: Neuropsychopharmacology
Year: 2014

Dexmedetomidine reduces the incidence of fentanyl-induced cough: a double-blind, randomized, and placebo-controlled study

Authors: L He, JM Xu, RP Dai
Journal: Upsala Journal of Medical Sciences
Year: 2012

Adipocyte fatty acid-binding protein promotes palmitate-induced mitochondrial dysfunction and apoptosis in macrophages

Authors: H Li, Y Xiao, L Tang, F Zhong, G Huang, JM Xu, AM Xu, RP Dai, ZG Zhou
Journal: Frontiers in Immunology
Year: 2018

Insulin-like growth factor 2 mitigates depressive behavior in a rat model of chronic stress

Authors: YW Luo, Y Xu, WY Cao, XL Zhong, J Duan, XQ Wang, ZL Hu, F Li, …
Journal: Neuropharmacology
Year: 2015

Biphasic activation of extracellular signal-regulated kinase in anterior cingulate cortex distinctly regulates the development of pain-related anxiety and mechanical …

Authors: RP Dai, CQ Li, JW Zhang, F Li, XD Shi, JY Zhang, XF Zhou
Journal: Anesthesiology
Year: 2011